Ms. Crossman is the Market Access Director for Gene Therapy at GlaxoSmithKline in London, United Kingdom, where she is responsible for developing and implementing market access strategies for GSK’s pipeline of Gene Therapies. Ms. Crossman has worked for GSK for the last 11 years in a variety of commercial leadership and market access roles, both at the global and local level. Prior to joining GSK, Ms. Crossman worked for Schering-Plough in Spain and the United States. Ms. Crossman currently is GSK’s representative for Rare Diseases to the Association of British Pharmaceutical Industry (ABPI) and she previously was Vice-President of an ABPI regional industry group. Ms. Crossman holds a BA from Dartmouth College and an MBA from Columbia University.